Dutasteride CAS NO.164656-23-9

Min.Order Quantity:: 100 Metric Ton

Purity:: 98%min

Port:: Qingdao,China

Payment Terms:: L/C,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

164656-23-9
Sell high quality Dutasteride produced in China factory
Dutasteride seller in China

Quick Details

ProName: Dutasteride
CasNo: 164656-23-9
Molecular Formula: C27H30F6N2O2
Appearance: white fine powder
Application: Used for research and industrial manuf...
DeliveryTime: Within7-10 days after receipt of your ...
PackAge: As customer request
Port: Qingdao,China
ProductionCapacity: 100kg/Month Metric Ton/Day
Purity: 98%min
Storage: Store in a cool,dry place and keep awa...
Transportation: Common products:Sea/Air/Courier Dange...
LimitNum: 100 Metric Ton

Superiority

triumph chemical title

triumph company office picture

triumph company advantage

triumph testing title picture

triumph testing way

welcome to contact us

lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details

quick details

proname: dutasteride 164656-23-9
casno: 164656-23-9
molecular formula: c27h30f6n2o2
appearance: detailed in specifcations
application: aripiprazole intermediate functional...
deliverytime: within 5days
package: as needed
port: china main port
productioncapacity: 500 metric ton/month
purity: 99%
storage: keep in dry and cool condition
transportation: by air or sea
limitnum: 1 kilogram
mf: c13h21o3ps

details

dutasteride basic information

clinical evaluation application

product name:	dutasteride
synonyms:	(5alpha,17beta)-n-{2,5-bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide;dutasteride;gg-745, gi-198745,;5α,17β)-n-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4- aza -androst-1-ene-17-carboxamide;duagen;(5a,17)-n-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide;avodart;gi 198745
cas:	164656-23-9
mf:	c27h30f6n2o2
mw:	528.53
einecs:
product categories:	miscellaneous biochemicals;all inhibitors;inhibitors;intermediates & fine chemicals;pharmaceuticals;steroids;steroid and hormone;hormone drugs;api
mol file:	164656-23-9.mol

dutasteride chemical properties

mp	242-250°c
storage temp.	-20°c freezer

safety information

msds information

dutasteride usage and synthesis

medicines to treat benign prostatic hyperplasia

on october 9, 2002, dutasteride that was developed by gsk was approved by the us food and drug administration for the use in the treatment of prostate enlargement.
on june 19, 2008, gsk announced that the fda approved for the combination of idutasteride and tamsulosin in the treatment of prostate hyperplasia.
in china, on of two elderly men over the age of 60 have benign prostatic hyperplasia. it can cause urinary tract symptoms, including significant rise in frequency of urination, thin urine flow, bladder emptying difficulties, as well as nocturia. it even can cause serious complications, like acute urinary retention, reduce the patients’ life quality, and affect their social life.
dutasteride is the first and the only dual 5α reductase inhibitor to be used in the treatment of prostatic hyperplasia. it can improve urinary system symptom, reduce the onset of acute urinary retention and the risk of prostate surgery. tamsulosin is α receptor blockers